InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: None

Thursday, 09/18/2014 8:23:52 AM

Thursday, September 18, 2014 8:23:52 AM

Post# of 427185
News Flash..

From Vascepa representitve,received today in my office.

Quote.

"DEAR DOCTOR

I am sorry I missed you today. I was hoping to share with you important information about VASCEPA(icosapent ethyl) the only FDA approved , pure EPA, prescription Omega-3. Indicated as an adjunct to diet in adult patients with very high triglycerides>500mg/dl), EPA-exclusive Vascepa offers proven efficacy alone or in combination with statin therapy, with tolerablity similar to placebo, and broad formulary coverage.

EPA-exclusive Vascepasignificantly lowers trig levels and improves multiple lipid parameters such as non-HDL-C and APO-B without raising LDL-C], as compared with placebo..."

Printed material goes on to list Aetna, Catamaran, Express Scrips National Formularies and a host of others..

I do not know whether this will trigger a response from the FDA or not...am crossing my fingers. Maybe Amarin is going First Amendment.

":>) JL

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News